Rohan Palekar

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rohan Palekar:

Stock Role Class Num Shares Value Price $ Report Date Ownership
89bio, Inc. Chief Executive Officer, Director Common Stock 0 $0 $14.70 30 Oct 2025 Direct
Neurogene Inc. Director Non-Qualified Stock Option (right to buy) 12.1K 12 Jun 2025 Direct
Neurogene Inc. Director Stock Option (Right to Buy) 7.7K 14 Jun 2024 Direct
89bio, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 0 30 Oct 2025 Direct

Insider Reports Filed by Rohan Palekar

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ETNB 89bio, Inc. 30 Oct 2025 10 $0 4 30 Oct 2025 Chief Executive Officer, Director
ETNB 89bio, Inc. 01 Aug 2025 1 -$511K 4 05 Aug 2025 Chief Executive Officer, Director
NGNE Neurogene Inc. 12 Jun 2025 1 $0 4 13 Jun 2025 Director
ETNB 89bio, Inc. 17 Feb 2025 1 -$34.3K 4 19 Feb 2025 Chief Executive Officer, Director
ETNB 89bio, Inc. 09 Feb 2025 1 -$102K 4 11 Feb 2025 Chief Executive Officer, Director
ETNB 89bio, Inc. 01 Feb 2025 4 -$92.1K 4 04 Feb 2025 Chief Executive Officer, Director
ETNB 89bio, Inc. 06 Dec 2024 1 $39.5K 4 10 Dec 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. 22 Nov 2024 1 $83.5K 4 25 Nov 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. 17 Aug 2024 1 -$37K 4 19 Aug 2024 Chief Executive Officer, Director
NGNE Neurogene Inc. 14 Jun 2024 1 $0 4 17 Jun 2024 Director
ETNB 89bio, Inc. 01 Apr 2024 3 -$527K 4 03 Apr 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. 26 Feb 2024 1 -$48.2K 4 28 Feb 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. 17 Feb 2024 1 -$44.8K 4 23 Feb 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. 09 Feb 2024 1 -$107K 4 13 Feb 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. 01 Feb 2024 3 -$49.7K 4 05 Feb 2024 Chief Executive Officer, Director
NGNE Neurogene Inc. 16 Jan 2024 1 $0 4 18 Jan 2024 Director
ETNB 89bio, Inc. 05 Jan 2024 2 -$317K 4 08 Jan 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. 29 Dec 2023 3 -$464K 4 03 Jan 2024 Chief Executive Officer, Director
ETNB 89bio, Inc. 17 Aug 2023 1 -$69.6K 4 21 Aug 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. 30 Jun 2023 2 -$313K 4 05 Jul 2023 Chief Executive Officer, Director
NLTX Neoleukin Therapeutics, Inc. 08 Jun 2023 1 $0 4 09 Jun 2023 Director
ETNB 89bio, Inc. 05 Jun 2023 3 -$271K 4 07 Jun 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. 31 Mar 2023 2 -$235K 4 04 Apr 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. 23 Mar 2023 1 -$240K 4 27 Mar 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. 17 Feb 2023 1 -$87.7K 4 22 Feb 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. 09 Feb 2023 2 $0 4 13 Feb 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. 05 Feb 2023 1 -$54K 4 07 Feb 2023 Chief Executive Officer, Director
ETNB 89bio, Inc. 28 Sep 2022 2 -$66.4K 4 30 Sep 2022 Chief Executive Officer, Director
ETNB 89bio, Inc. 08 Sep 2022 2 $193K 4 09 Sep 2022 Chief Executive Officer, Director
NLTX Neoleukin Therapeutics, Inc. 12 May 2022 1 $0 4 16 May 2022 Director
NLTX Neoleukin Therapeutics, Inc. 02 Mar 2022 1 $0 4 04 Mar 2022 Director
NLTX Neoleukin Therapeutics, Inc. 02 Mar 2022 0 $0 3 04 Mar 2022 Director
ETNB 89bio, Inc. 17 Feb 2022 2 $0 4 22 Feb 2022 Chief Executive Officer, Director
ETNB 89bio, Inc. 05 Feb 2022 1 -$21.4K 4 13 Apr 2022 Chief Executive Officer, Director
ETNB 89bio, Inc. 27 Jan 2022 2 $52.9K 4 31 Jan 2022 Chief Executive Officer, Director
ETNB 89bio, Inc. 07 Jul 2021 2 $118K 4 08 Jul 2021 Chief Executive Officer, Director